- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
12
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
12 companies
Lee's Pharmaceutical Holdings
Market Cap: HK$1.3b
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.
950
HK$2.12
7D
19.8%
1Y
75.2%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.11
7D
-0.9%
1Y
48.6%
Alphamab Oncology
Market Cap: HK$9.3b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.
9966
HK$9.45
7D
3.4%
1Y
314.5%
Jacobson Pharma
Market Cap: HK$2.9b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.43
7D
-2.1%
1Y
146.6%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$10.2b
A biotechnology company, engages in the research and development of novel antibody-based drugs in the People’s Republic of China, the United States, and internationally.
2315
HK$25.64
7D
22.9%
1Y
308.9%
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$3.00
7D
3.8%
1Y
237.1%
Medtide
Market Cap: HK$5.2b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$34.80
7D
-7.5%
1Y
n/a
Essex Bio-Technology
Market Cap: HK$3.1b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.17
7D
-1.7%
1Y
124.8%
Viva Biotech Holdings
Market Cap: HK$6.0b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$2.71
7D
16.3%
1Y
367.2%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.80
7D
-4.2%
1Y
17.3%
HBM Holdings
Market Cap: HK$12.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$15.99
7D
25.9%
1Y
1,315.0%
Consun Pharmaceutical Group
Market Cap: HK$12.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.20
7D
6.7%
1Y
181.5%